The 12-Month Warning: Your Members Are Already Telling You What Your 2027 Claims Will Look Like

The most valuable benefits intelligence isn't in last year's claims report. It's in what your employees are telling you right now.

Most benefits strategies are built on a data signal that arrives too late to change outcomes.

Claims data is the most available signal for managing population health risk, but it's a lagging one. The gap between when a health event occurs and when it appears in a claims report is where cost trajectories are set, conditions escalate, and the window for proactive intervention closes. 

Claims data is a record of what’s already happened. By the time a chronic condition surfaces in a plan report, it has been progressing unmanaged for months. By the time a cancer diagnosis hits a claims file, the detection window has already closed. By the time GLP-1 spend appears on a pharmacy analysis, the member has been on an unsupervised prescription for a quarter, sometimes longer.

The employers who will control their 2027 costs aren’t waiting for that data. They’re reading a different signal entirely.

What Member Intent Data Is — And Why It Arrives Earlier

Every year, HealthJoy analyzes the self-reported health goals, concerns, and intentions of hundreds of thousands of members, alongside population health data to surface the risks building in employer populations before they appear in claims. The intent data, what members report they're experiencing, planning, and struggling with, arrives months before a billing system ever sees it. Combined with population health trends, it gives employers a signal that is both earlier and more actionable than claims data alone. 

That distinction matters more than it might initially seem. The average lag between a health event and its appearance in analyzable claims data is 12 to 18 months when you account for claims processing, adjudication, and reporting cycles. That’s an entire plan year — the window in which cost trajectories are set, chronic conditions progress, and surgical pipelines build — which most benefits strategies aren't currently designed to look at.

Member intent data closes that gap. It’s self-reported, directional, and population-level rather than individually clinical. But as a leading indicator of where workforce health is headed, it provides something claims data structurally cannot: enough time to act.

What the 2026 Data Is Already Telling Us

HealthJoy's 2026 Member Health Goals Report that’s built on self-reported data from more than 100,000 members, isn’t only a retrospective look at 2025. It’s a forward-looking map of the claims currently building in the 2026 and 2027 pipeline. Read through that lens, each finding stops being a trend to worry about and becomes a specific, actionable warning signal.

The preventive care collapse is a 2027 chronic condition and cancer claim. Just 17% of members plan to complete an annual physical this year, a 45.3% drop in stated intent in a single year. That number isn’t a wellness statistic, it’s a leading indicator. When members skip preventive visits at this scale, chronic conditions go undetected, cancer screenings are missed, and mental health concerns are never surfaced to a clinician. The claims consequences of that gap are already beginning to surface, and will continue to accelerate through 2027. The window to interrupt that trajectory is now, not then.

The GLP-1 demand surge is a pharmacy budget event already in progress. Nearly 60% of members report a weight loss goal as of early 2026, up from 55% at year-end 2025. GLP-1 demand is running ahead of most plan designs, and the employers who don’t have a structured eligibility and oversight framework in place before their next renewal will face a cost conversation they weren’t prepared for.

The MSK and mental health comorbidity is a compounding cost driver hiding in plain sight. 35% of members report chronic back or joint pain, and 60.6% of those members also report a mental health struggle. These aren’t parallel benefit categories. They’re entangled conditions that amplify each other and drive utilization that’s more expensive precisely because it’s being addressed in isolation. The member in chronic pain who’s also struggling mentally isn’t being routed to integrated care. They’re being routed to two separate vendors who don’t communicate, and the cost of that disconnection compounds with every month it goes unaddressed.

The millennial and Gen Z cancer signal is building in a cohort most stop-loss strategies aren't priced for. Members aged 26 to 35 reported a 25% increase year-over-year in cancer concerns in 2025, the second consecutive year of elevated rates in this cohort. Younger adults aren’t on most employers' high-risk radar for oncology, but the self-reported signal in this data suggests they should be. A sustained increase in cancer-related concerns among a population least likely to have a cancer management strategy in place means employers are one diagnosis away from a claim that reshapes their stop-loss conversation, and potentially their carrier relationship.

The Gen Z prescription affordability gap is a slow-building cost escalation. Members aged 18 to 25 saw a 6.87% increase in prescription costs year over year. Rising prescription burden at this age signals emerging chronic conditions and affordability-driven non-adherence: members rationing or abandoning medications because of cost. That pattern doesn’t show up in this year's claims. It shows up as an escalated condition and an expensive intervention three to five years from now. The signal is subtle, the trajectory is not.

Why the Current Architecture Can’t Act on These Signals

Knowing the signals exist isn’t enough. The reason most employers can’t act on them is structural.

When a member's primary care visit lives in the carrier network, their mental health benefit lives with a separate program, their MSK program is a third point solution, and their pharmacy benefit is managed by a PBM with its own incentive structure, there’s no system watching for the member's weight loss goal in February and connecting it to their chronic condition flag in March or their mental health claim in April.

Most benefits architectures aren't designed to read it.

This isn’t a data problem. The data exists — in member goals, platform interactions, and self-reported health concerns. It’s an architecture problem. Fragmented benefits systems aren’t designed to connect those signals to interventions. They’re designed to process transactions. And transaction processing, by definition, is reactive.

The result is a benefits ecosystem that’s comprehensive on paper but harder to navigate in practice with every point solution added. A member who falls through the gap between a pain complaint and a mental health referral isn’t failing to use their benefits. They’re navigating a system that was never built to connect the dots for them. And every time that happens, the cost of the missed connection lands somewhere on the plan.

What Predictive Steerage Actually Looks Like

The shift that changes the cost trajectory isn’t adding more benefits. It’s having a system that acts on the signals members are already sending, before those signals become claims.

In practice, that means three things:

1. A single system with visibility into the whole member. Not the member's carrier claims. Not their EAP utilization. Not their pharmacy fills. All of it: goals, conditions, benefit options, utilization history, in one place, available in real time. Without that unified view, predictive intervention isn’t possible because you can’t act on a signal you can’t see.

2. AI-driven identification of risk before it becomes utilization. The members who are most likely to generate high-cost claims in 2027 are identifiable today, not through claims data, but through the intent signals they’re already expressing. A member who sets a weight loss goal, has a chronic condition health trait, and hasn’t completed a preventive visit this year isn’t a random risk. They’re a specific, identifiable, actionable risk. A system that can surface that member and route them to the right intervention before the claim happens isn’t theoretical. It’s what separates a proactive benefits strategy from a reactive one.

3. Steerage that removes friction rather than adding messaging. The difference between a member who uses their benefits at the right moment and one who doesn’t is rarely awareness, it’s friction. A system that identifies a member as overdue for a preventive screening and connects them directly to an available in-network provider — rather than sending a generic reminder — isn’t a better communications strategy. It’s a fundamentally different architecture.

The Closing Argument

The employers who’ll control their 2027 costs made different decisions in 2025 and 2026. Not because they had better benefits, but because they had a system that could read the signals their members were already sending and act on them before the claims arrived.

The signals are already there: in the appointments not being made, the prescriptions being abandoned, the pain complaints that are also mental health struggles, the millennials whose cancer concerns are outpacing most plan designs.

What you do with those signals between now and your next renewal is the decision that will define your 2027 cost trajectory.

This article draws on findings from HealthJoy's 2026 Member Health Goals Report, based on self-reported health intent data from 106,768 members collected January 1, 2025 – February 28, 2026. All findings reflect member-reported goals and intentions, not claims or clinical outcomes data.

Download the full 2026 Member Health Goals Report